{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:17:42Z","timestamp":1791206262283,"version":"4.1.0"},"reference-count":117,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1681\/asn.2015020184","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T21:40:07Z","timestamp":1437082807000},"page":"2917-2929","source":"Crossref","is-referenced-by-count":83,"title":["Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway"],"prefix":"10.1681","volume":"26","author":[{"given":"An S.","family":"De Vriese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Van Praet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl A.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20230208","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","article-title":"Overview of complement activation and regulation.","volume":"33","author":"Noris","year":"2013","journal-title":"Semin Nephrol"},{"key":"R2-8-20230208","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease.","volume":"176","author":"Thurman","year":"2006","journal-title":"J Immunol"},{"key":"R3-8-20230208","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: Consensus report.","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"R4-8-20230208","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-0034-1375701","article-title":"Pathology of renal diseases associated with dysfunction of the alternative pathway of complement: C3 glomerulopathy and atypical hemolytic uremic syndrome (aHUS).","volume":"40","author":"Sethi","year":"2014","journal-title":"Semin Thromb Hemost"},{"key":"R5-8-20230208","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nrneph.2012.213","article-title":"Pathogenesis of the C3 glomerulopathies and reclassification of MPGN.","volume":"8","author":"Bomback","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R6-8-20230208","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ki.2012.384","article-title":"Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement.","volume":"83","author":"Sethi","year":"2013","journal-title":"Kidney Int"},{"key":"R7-8-20230208","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4049\/jimmunol.1302288","article-title":"Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: Possible implications in C3 glomerulopathies.","volume":"192","author":"Ramadass","year":"2014","journal-title":"J Immunol"},{"key":"R8-8-20230208","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ki.2014.49","article-title":"The etiology of glomerulonephritis: Roles of infection and autoimmunity.","volume":"86","author":"Couser","year":"2014","journal-title":"Kidney Int"},{"key":"R9-8-20230208","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.","volume":"68","author":"P\u00e9rez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R10-8-20230208","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejim.2012.12.016","article-title":"The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.","volume":"24","author":"Boels","year":"2013","journal-title":"Eur J Intern Med"},{"key":"R11-8-20230208","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00467-012-2210-0","article-title":"Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: Report of a case.","volume":"27","author":"Gnappi","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"R12-8-20230208","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.ki.5000155","article-title":"Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome.","volume":"69","author":"Vaziri-Sani","year":"2006","journal-title":"Kidney Int"},{"key":"R13-8-20230208","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/08860229809045182","article-title":"Secondary membranoproliferative glomerulonephritis due to hemolytic uremic syndrome: An unusual presentation.","volume":"20","author":"Jha","year":"1998","journal-title":"Ren Fail"},{"key":"R14-8-20230208","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/ndt\/gft220","article-title":"Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature.","volume":"28","author":"Manenti","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R15-8-20230208","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.ajkd.2007.11.032","article-title":"Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.","volume":"51","author":"Boyer","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R16-8-20230208","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/ndt\/gfr436","article-title":"Three kidneys, two diseases, one antibody?","volume":"26","author":"Lorcy","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R17-8-20230208","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/ndt\/gfr422","article-title":"Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.","volume":"26","author":"Brackman","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R18-8-20230208","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/ki.2012.220","article-title":"The many faces of C3 glomerulopathy.","volume":"82","author":"Meleg-Smith","year":"2012","journal-title":"Kidney Int"},{"key":"R19-8-20230208","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1053\/j.ajkd.2012.04.032","article-title":"C3 glomerulopathy masquerading as acute postinfectious glomerulonephritis.","volume":"60","author":"Sandhu","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R20-8-20230208","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.","volume":"24","author":"Bresin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R21-8-20230208","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1182\/blood-2011-10-383281","article-title":"A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.","volume":"119","author":"Roumenina","year":"2012","journal-title":"Blood"},{"key":"R22-8-20230208","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R23-8-20230208","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ki.2012.63","article-title":"Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.","volume":"82","author":"Servais","year":"2012","journal-title":"Kidney Int"},{"key":"R24-8-20230208","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1016\/j.molimm.2008.01.027","article-title":"Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.","volume":"45","author":"Montes","year":"2008","journal-title":"Mol Immunol"},{"key":"R25-8-20230208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/gene.2010.63","article-title":"Complement factor H deficiency and endocapillary glomerulonephritis due to paternal isodisomy and a novel factor H mutation.","volume":"12","author":"Schejbel","year":"2011","journal-title":"Genes Immun"},{"key":"R26-8-20230208","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.humpath.2010.11.023","article-title":"Heterogeneous pattern of renal disease associated with homozygous factor H deficiency.","volume":"42","author":"Servais","year":"2011","journal-title":"Hum Pathol"},{"key":"R27-8-20230208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molimm.2005.06.015","article-title":"Complement and diseases: Defective alternative pathway control results in kidney and eye diseases.","volume":"43","author":"Zipfel","year":"2006","journal-title":"Mol Immunol"},{"key":"R28-8-20230208","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ki.2008.354","article-title":"C3 deposition glomerulopathy due to a functional factor H defect.","volume":"75","author":"Habbig","year":"2009","journal-title":"Kidney Int"},{"key":"R29-8-20230208","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.ki.5000269","article-title":"Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).","volume":"70","author":"Licht","year":"2006","journal-title":"Kidney Int"},{"key":"R30-8-20230208","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1681\/ASN.2013070732","article-title":"Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.","volume":"25","author":"Wong","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R31-8-20230208","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00467-010-1734-4","article-title":"Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.","volume":"26","author":"Leroy","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R32-8-20230208","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2215\/CJN.07110810","article-title":"Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.","volume":"6","author":"Sethi","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-8-20230208","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1681\/ASN.2011030304","article-title":"Basic and translational concepts of immune-mediated glomerular diseases.","volume":"23","author":"Couser","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R34-8-20230208","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.ajkd.2012.03.007","article-title":"Association of a novel complement factor H mutation with severe crescentic and necrotizing glomerulonephritis.","volume":"60","author":"Fervenza","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R35-8-20230208","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R36-8-20230208","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2215\/CJN.01260212","article-title":"Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.","volume":"8","author":"Hofer","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R37-8-20230208","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","article-title":"Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency.","volume":"111","author":"J\u00f3zsi","year":"2008","journal-title":"Blood"},{"key":"R38-8-20230208","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"key":"R39-8-20230208","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ki.2013.373","article-title":"Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children.","volume":"85","author":"Sinha","year":"2014","journal-title":"Kidney Int"},{"key":"R40-8-20230208","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.1200679","article-title":"Overall neutralization of complement factor H by autoantibodies in the acute phase of the autoimmune form of atypical hemolytic uremic syndrome.","volume":"189","author":"Blanc","year":"2012","journal-title":"J Immunol"},{"key":"R41-8-20230208","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1084\/jem.175.4.939","article-title":"Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis.","volume":"175","author":"Meri","year":"1992","journal-title":"J Exp Med"},{"key":"R42-8-20230208","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.4049\/jimmunol.163.8.4590","article-title":"Nephritogenic lambda light chain dimer: A unique human miniautoantibody against complement factor H.","volume":"163","author":"Jokiranta","year":"1999","journal-title":"J Immunol"},{"key":"R43-8-20230208","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.05.009","article-title":"Factor H autoantibodies in membranoproliferative glomerulonephritis.","volume":"52","author":"Goodship","year":"2012","journal-title":"Mol Immunol"},{"key":"R44-8-20230208","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2215\/CJN.07900811","article-title":"Causes of alternative pathway dysregulation in dense deposit disease.","volume":"7","author":"Zhang","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R45-8-20230208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs).","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"R46-8-20230208","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1073\/pnas.1219260110","article-title":"Dimerization of complement factor H-related proteins modulates complement activation in vivo.","volume":"110","author":"Goicoechea de Jorge","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R47-8-20230208","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2215\/CJN.09541010","article-title":"Familial C3 glomerulopathy associated with CFHR5 mutations: Clinical characteristics of 91 patients in 16 pedigrees.","volume":"6","author":"Athanasiou","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R48-8-20230208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI71866","article-title":"Complement factor H-related hybrid protein deregulates complement in dense deposit disease.","volume":"124","author":"Chen","year":"2014","journal-title":"J Clin Invest"},{"key":"R49-8-20230208","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(10)60670-8","article-title":"Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.","volume":"376","author":"Gale","year":"2010","journal-title":"Lancet"},{"key":"R50-8-20230208","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1681\/ASN.2012020166","article-title":"A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.","volume":"23","author":"Malik","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R51-8-20230208","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ki.2013.348","article-title":"A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.","volume":"85","author":"Medjeral-Thomas","year":"2014","journal-title":"Kidney Int"},{"key":"R52-8-20230208","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1172\/JCI68280","article-title":"C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation.","volume":"123","author":"Tortajada","year":"2013","journal-title":"J Clin Invest"},{"key":"R53-8-20230208","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1371\/journal.pmed.0030431","article-title":"Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.","volume":"3","author":"Venables","year":"2006","journal-title":"PLoS Med"},{"key":"R54-8-20230208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/ndt\/gfq658","article-title":"A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.","volume":"26","author":"Maga","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R55-8-20230208","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00467-013-2560-2","article-title":"A novel hybrid CFHR1\/CFH gene causes atypical hemolytic uremic syndrome.","volume":"28","author":"Eyler","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R56-8-20230208","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1681\/ASN.2013121339","article-title":"A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1\/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.","volume":"26","author":"Valoti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R57-8-20230208","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2011-03-339903","article-title":"A novel hybrid CFH\/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.","volume":"119","author":"Francis","year":"2012","journal-title":"Blood"},{"key":"R58-8-20230208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.ajkd.2012.02.329","article-title":"Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency.","volume":"60","author":"Vernon","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"R59-8-20230208","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10875-014-0058-8","article-title":"A complement factor B mutation in a large kindred with atypical hemolytic uremic syndrome.","volume":"34","author":"Funato","year":"2014","journal-title":"J Clin Immunol"},{"key":"R60-8-20230208","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0603420103","article-title":"Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.","volume":"104","author":"Goicoechea de Jorge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R61-8-20230208","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2013070796","article-title":"Complement factor B mutations in atypical hemolytic uremic syndrome\u2013disease-relevant or benign?","volume":"25","author":"Marinozzi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R62-8-20230208","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood-2009-01-197640","article-title":"Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.","volume":"114","author":"Roumenina","year":"2009","journal-title":"Blood"},{"key":"R63-8-20230208","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"R64-8-20230208","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.2215\/CJN.06281208","article-title":"A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.","volume":"4","author":"Lhotta","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R65-8-20230208","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1159\/000167525","article-title":"Hypocomplementemic glomerulonephritis in an infant and mother. Evidence for an abnormal form of C3.","volume":"7","author":"Linshaw","year":"1987","journal-title":"Am J Nephrol"},{"key":"R66-8-20230208","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.1983.89","article-title":"An inherited defect in the C3 convertase, C3b,Bb, associated with glomerulonephritis.","volume":"23","author":"Marder","year":"1983","journal-title":"Kidney Int"},{"key":"R67-8-20230208","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1172\/JCI43343","article-title":"Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.","volume":"120","author":"Mart\u00ednez-Barricarte","year":"2010","journal-title":"J Clin Invest"},{"key":"R68-8-20230208","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis.","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R69-8-20230208","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.2012.212","article-title":"C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.","volume":"82","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"key":"R70-8-20230208","first-page":"1747","article-title":"Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity.","volume":"9","author":"Fremeaux-Bacchi","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"R71-8-20230208","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(72)91740-0","article-title":"C3 breakdown by serum from patients with acute post-streptococcal nephritis.","volume":"2","author":"Williams","year":"1972","journal-title":"Lancet"},{"key":"R72-8-20230208","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-1229(90)90018-L","article-title":"Production of IgG and IgM autoantibody to the alternative pathway C3 convertase in normal individuals and patients with membranoproliferative glomerulonephritis.","volume":"57","author":"Spitzer","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"R73-8-20230208","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJMc1106619","article-title":"Eculizumab and refractory membranoproliferative glomerulonephritis.","volume":"366","author":"Radhakrishnan","year":"2012","journal-title":"N Engl J Med"},{"key":"R74-8-20230208","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00467-013-2711-5","article-title":"Rituximab fails where eculizumab restores renal function in C3nef-related DDD.","volume":"29","author":"Rousset-Rouvi\u00e8re","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R75-8-20230208","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJMc1112273","article-title":"Eculizumab in a patient with dense-deposit disease.","volume":"366","author":"Daina","year":"2012","journal-title":"N Engl J Med"},{"key":"R76-8-20230208","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5414\/CN107945","article-title":"Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy.","volume":"83","author":"Giaime","year":"2015","journal-title":"Clin Nephrol"},{"key":"R77-8-20230208","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.molimm.2010.02.002","article-title":"Anti-factor B autoantibody in dense deposit disease.","volume":"47","author":"Strobel","year":"2010","journal-title":"Mol Immunol"},{"key":"R78-8-20230208","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMc1107484","article-title":"Combined C3b and factor B autoantibodies and MPGN type II.","volume":"365","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"R79-8-20230208","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1136\/jmg.2004.019083","article-title":"Complement factor I: A susceptibility gene for atypical haemolytic uraemic syndrome.","volume":"41","author":"Fremeaux-Bacchi","year":"2004","journal-title":"J Med Genet"},{"key":"R80-8-20230208","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2005010103","article-title":"Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.","volume":"16","author":"Kavanagh","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R81-8-20230208","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","article-title":"Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.","volume":"108","author":"Caprioli","year":"2006","journal-title":"Blood"},{"key":"R82-8-20230208","first-page":"608","article-title":"Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice.","volume":"118","author":"Rose","year":"2008","journal-title":"J Clin Invest"},{"key":"R83-8-20230208","first-page":"385","article-title":"Hereditary complement factor I deficiency.","volume":"87","author":"Vyse","year":"1994","journal-title":"QJM"},{"key":"R84-8-20230208","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"R85-8-20230208","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1053\/j.ajkd.2008.02.359","article-title":"Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair.","volume":"52","author":"Couzi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R86-8-20230208","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.2215\/CJN.06180710","article-title":"Glomerulonephritis with isolated C3 deposits and monoclonal gammopathy: A fortuitous association?","volume":"6","author":"Bridoux","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R87-8-20230208","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/003130201201117945","article-title":"Membranoproliferative glomerulonephritis in association with chronic lymphocytic leukaemia: A report of three cases.","volume":"34","author":"Hill","year":"2002","journal-title":"Pathology"},{"key":"R88-8-20230208","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy.","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R89-8-20230208","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1053\/j.ajkd.2013.02.370","article-title":"C3 glomerulonephritis associated with monoclonal gammopathy: A case series.","volume":"62","author":"Zand","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R90-8-20230208","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2215\/CJN.03480708","article-title":"Dense deposit disease: Clinicopathologic study of 32 pediatric and adult patients.","volume":"4","author":"Nasr","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R91-8-20230208","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1093\/oxfordjournals.ndt.a027156","article-title":"Dense deposit disease in association with monoclonal gammopathy of unknown significance.","volume":"11","author":"Sepandj","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R92-8-20230208","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.ajkd.2010.06.021","article-title":"Dense deposit disease associated with monoclonal gammopathy of undetermined significance.","volume":"56","author":"Sethi","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R93-8-20230208","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1055\/s-0030-1262890","article-title":"Plasmatherapy in atypical hemolytic uremic syndrome.","volume":"36","author":"Loirat","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"R94-8-20230208","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00467-009-1188-8","article-title":"Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome.","volume":"24","author":"Davin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R95-8-20230208","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R96-8-20230208","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00467-013-2722-2","article-title":"Liver-kidney transplantation to cure atypical HUS: Still an option post-eculizumab?","volume":"29","author":"Saland","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R97-8-20230208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00467-013-2630-5","article-title":"Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.","volume":"29","author":"Tran","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R98-8-20230208","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/01.ASN.0000115702.28859.A7","article-title":"Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases.","volume":"15","author":"Dragon-Durey","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R99-8-20230208","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/bmj.284.6332.1874-b","article-title":"Acute renal failure in dense deposit disease: Recovery after plasmapheresis.","volume":"284","author":"Banks","year":"1982","journal-title":"Br Med J (Clin Res Ed"},{"key":"R100-8-20230208","first-page":"4","article-title":"Acute renal failure in dense deposit disease: Complete recovery after combination therapy with immunosuppressant and plasma exchange.","volume":"75","author":"Krmar","year":"2011","journal-title":"Clin Nephrol"},{"key":"R101-8-20230208","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jca.10026","article-title":"Management of membranoproliferative glomerulonephritis type II with plasmapheresis.","volume":"17","author":"Kurtz","year":"2002","journal-title":"J Clin Apher"},{"key":"R102-8-20230208","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/j.ajkd.2009.12.026","article-title":"Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.","volume":"55","author":"Boyer","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R103-8-20230208","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1681\/ASN.2013070715","article-title":"Clinical findings, pathology, and outcomes of C3GN after kidney transplantation.","volume":"25","author":"Zand","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R104-8-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4614-4118-2_1","article-title":"Progress and trends in complement therapeutics.","volume":"735","author":"Ricklin","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"R105-8-20230208","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R106-8-20230208","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.ajkd.2013.07.011","article-title":"Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: An analysis of 19 cases.","volume":"63","author":"Fakhouri","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R107-8-20230208","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R108-8-20230208","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab.","volume":"370","author":"Nishimura","year":"2014","journal-title":"N Engl J Med"},{"key":"R109-8-20230208","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1600-6143.2011.03923.x","article-title":"Recurrent dense deposit disease after renal transplantation: An emerging role for complementary therapies.","volume":"12","author":"McCaughan","year":"2012","journal-title":"Am J Transplant"},{"key":"R110-8-20230208","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00467-013-2748-5","article-title":"Eculizumab therapy in a patient with dense-deposit disease associated with partial lipodystropy.","volume":"29","author":"Ozkaya","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R111-8-20230208","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1007\/s00467-014-2839-y","article-title":"Eculizumab in dense-deposit disease after renal transplantation.","volume":"29","author":"S\u00e1nchez-Moreno","year":"2014","journal-title":"Pediatr Nephrol"},{"key":"R112-8-20230208","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMc1111953","article-title":"Eculizumab for the treatment of dense-deposit disease.","volume":"366","author":"Vivarelli","year":"2012","journal-title":"N Engl J Med"},{"key":"R113-8-20230208","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00467-013-2503-y","article-title":"Eculizumab and recurrent C3 glomerulonephritis.","volume":"28","author":"Gurkan","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"R114-8-20230208","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2011121186","article-title":"Pathology after eculizumab in dense deposit disease and C3 GN.","volume":"23","author":"Herlitz","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R115-8-20230208","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.2215\/CJN.01820214","article-title":"Defining the complement biomarker profile of C3 glomerulopathy.","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R116-8-20230208","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.4049\/jimmunol.1303131","article-title":"A humanized antibody that regulates the alternative pathway convertase: Potential for therapy of renal disease associated with nephritic factors.","volume":"192","author":"Paix\u00e3o-Cavalcante","year":"2014","journal-title":"J Immunol"},{"key":"R117-8-20230208","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1681\/ASN.2013010045","article-title":"Soluble CR1 therapy improves complement regulation in C3 glomerulopathy.","volume":"24","author":"Zhang","year":"2013","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:46Z","timestamp":1786130806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00008"}},"subtitle":["An Etiologic Approach"],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":117,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2015020184","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}